Cellares Corp reported raising $82 Million in an initial SEC Form D filing, from an offering of $82 Million
PRIVATEMay 11, 2021
Amount Raised
$82 Million
$82 Million sold, per SEC Form D (first sale May 11, 2021)
Round Type
Venture
South San FranciscoManufacturingBiotechnology
Quick answer
Cellares raised $82 Million in a funding round, dated May 11, 2021. Cellares is based in South San Francisco, California, United States.
How much did Cellares raise?
Cellares raised $82 Million in a funding round on May 11, 2021.
What does Cellares do?
Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century.
Where is Cellares based and how big is it?
Cellares is based in South San Francisco, California, United States. Fundz records about 300 employees.
Who are the decision-makers at Cellares?
Fundz holds 1 contact at Cellares, including the Co-Founder & CEO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who to call at Cellares, and when
A new round usually means Cellares is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Cellares raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Cellares, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cellares. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Cellares
Location
345 ALLERTON AVE
South San Francisco, California, United States
About
Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century. The company is both developing and operating integrated technologies for cell therapy manufacturing to accelerate access to life-saving cell therapies. The company’s Cell Shuttle integrates all the technologies required for the entire manufacturing process in a flexible and high-throughput platform that delivers true walk-away, end-to-end automation. Cell Shuttles will be deployed in Cellares’ Smart Factories around the world to meet total patient demand for cell therapies at global scale. Partnering with Cellares enables academics, biotechs, and pharma companies to accelerate drug development and scale out manufacturing, lower process failure rates, lower manufacturing costs, and meet global patient demand.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cellares raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.